Sanjeev N Mehta
Overview
Explore the profile of Sanjeev N Mehta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
621
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barber R, Volkening L, Mehta S, Dassau E, Laffel L
Diabetes Technol Ther
. 2024 Jan;
26(6):420-425.
PMID: 38277162
Insulin bolus doses derive from glucose levels and planned carbohydrate intake, although fat and protein impact glycemic excursions. We examined the impact of macronutrients and number of daily meals/snacks on...
2.
Criego A, Carlson A, Brown S, Forlenza G, Bode B, Levy C, et al.
Diabetes Technol Ther
. 2023 Oct;
26(1):11-23.
PMID: 37850941
The Omnipod 5 Automated Insulin Delivery (AID) System was shown to be safe and effective following 3 months of use in people with type 1 diabetes (T1D); however, data on...
3.
Polonsky W, Hood K, Levy C, MacLeish S, Hirsch I, Brown S, et al.
Diabetes Res Clin Pract
. 2022 Jul;
190:109998.
PMID: 35853530
Aims: To evaluate psychosocial outcomes for adults with type 1 diabetes (T1D) using the tubeless Omnipod® 5 Automated Insulin Delivery (AID) System. Methods: A single-arm, multicenter (across the United States),...
4.
Essien U, Tang Y, Figueroa J, Litam T, Tang F, Jones P, et al.
Diabetes Care
. 2022 Jul;
45(7):1549-1557.
PMID: 35796766
Objective: Medicare Advantage (MA), Medicare's managed care program, is quickly expanding, yet little is known about diabetes care quality delivered under MA compared with traditional fee-for-service (FFS) Medicare. Research Design...
5.
Brown S, Forlenza G, Bode B, Pinsker J, Levy C, Criego A, et al.
Diabetes Care
. 2021 Jun;
44(7):1630-1640.
PMID: 34099518
Objective: Advances in diabetes technology have transformed the treatment paradigm for type 1 diabetes, yet the burden of disease is significant. We report on a pivotal safety study of the...
6.
Ahern D, Aberger E, Wroblewski J, Zheng Q, Mehta S, Buchanan A, et al.
Am J Manag Care
. 2021 Mar;
27(3):96-102.
PMID: 33720666
Objectives: To (1) examine the impact of the Diabetes Care Rewards (DCR) program on adherence to care standards and (2) evaluate the economic impact of adherence to care standards. Study...
7.
Mehta S, Tinsley L, Kruger D, Bode B, Layne J, Huyett L, et al.
Clin Diabetes
. 2021 Feb;
39(1):72-79.
PMID: 33551556
Continuous subcutaneous insulin infusion (CSII) treatment may improve long-term glycemic outcomes and enhance quality of life compared with a multiple daily injection (MDI) insulin regimen for people with type 1...
8.
Tinsley L, Wong N, Reusch J, Arnold S, Kosiborod M, Tang Y, et al.
J Diabetes Complications
. 2020 May;
34(8):107591.
PMID: 32471789
Aims: To compare cardiovascular risk factor control in adults with diabetes participating in a national diabetes registry to those in the general population and to ascertain regional differences in diabetes...
9.
Shah V, Bailey R, Wu M, Foster N, Pop-Busui R, Katz M, et al.
J Clin Endocrinol Metab
. 2020 Jan;
105(5).
PMID: 31955209
Context: Cardiovascular disease (CVD) is a major cause of mortality in adults with type 1 diabetes. Objective: We prospectively evaluated CVD risk factors in a large, contemporary cohort of adults...
10.
Arnold S, McGuire D, Inzucchi S, Tang F, Mehta S, Lam C, et al.
J Diabetes Complications
. 2018 Sep;
32(11):1035-1039.
PMID: 30177468
Background: Although practice guidelines stress individualization of glucose management in patients with type 2 diabetes (T2D), the extent to which providers take patient factors into account when selecting medications is...